
Positive, helpful, and upbeat. These aren’t words you would expect to describe someone about to start another round of chemo treatment. However, in the case of Suzan Mickey, they are very apt. Mickey is a participant in the 23andMe and Genentech InVite study on bevacizumab (also known as Avastin®) and [...]







